Gilead Sciences, Inc. (BIT:1GILD)
92.49
-1.16 (-1.24%)
Last updated: Apr 17, 2025
Gilead Sciences Revenue
In the year 2024, Gilead Sciences had annual revenue of $28.75B USD with 6.04% growth. Gilead Sciences had revenue of $7.57B in the quarter ending December 31, 2024, with 6.40% growth.
Revenue
$28.75B
Revenue Growth
+6.04%
P/S Ratio
4.13
Revenue / Employee
$1.63M
Employees
17,600
Market Cap
114.61B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 28.75B | 1.64B | 6.04% |
Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Recordati Industria Chimica e Farmaceutica | 2.34B |
DiaSorin | 1.19B |
Amplifon | 2.41B |
Philogen | 77.65M |
EL.En. | 565.85M |
Pharmanutra | 116.15M |
Garofalo Health Care | 467.77M |
Safilo Group | 993.22M |